| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| UTHR | Stock | Healthcare | US$ 23.23 B | 2,95% | |
| XERS | Stock | Healthcare | US$ 1.66 B | 2,82% | |
| LGND | Stock | Healthcare | US$ 6.04 B | 2,81% | |
| RARE | Stock | Healthcare | US$ 1.51 B | 2,77% | |
Basilea Pharmaceutica AG
|
BSLN | Stock | Healthcare | US$ 827.78 M | 2,70% |
| GEN | Stock | Other | US$ 18.35 B | 2,68% | |
| BGNE | Stock | Healthcare | US$ 20.21 B | 2,65% | |
| HALO | Stock | Healthcare | US$ 12.47 B | 2,65% | |
| BIIB | Stock | Healthcare | US$ 32.63 B | 2,64% | |
|
Eisai Co. Ltd.
|
4523 | - | Healthcare | - | 2,63% |
Recordati Industria Chimica e Farmaceutica S.p.A.
|
REC_old | Stock | Healthcare | US$ 10.30 B | 2,61% |
| AZN | Stock | Healthcare | US$ 243.34 B | 2,57% | |
|
Nippon Shinyaku Co Ltd
|
4516 | - | Healthcare | - | 2,57% |
| RIGL | Stock | Healthcare | US$ 880.76 M | 2,56% | |
| AGIO | Stock | Healthcare | US$ 1.90 B | 2,54% | |
| JAZZ | Stock | Healthcare | US$ 15.30 B | 2,54% | |
| XNCR | Stock | Healthcare | US$ 1.85 B | 2,47% | |
LG Chemicals
|
051910 | Stock | Basic Materials | US$ 20.55 T | 2,47% |
| JNJ | Stock | Healthcare | US$ 663.28 B | 2,46% | |
| VRTX | Stock | Healthcare | US$ 141.42 B | 2,45% | |
| AMGN | Stock | Healthcare | US$ 240.11 B | 2,44% | |
|
Kyowa Kirin Co Ltd
|
4151 | - | Healthcare | - | 2,43% |
| PTCT | Stock | Healthcare | US$ 5.30 B | 2,42% | |
| INCY | Stock | Healthcare | US$ 25.69 B | 2,41% | |
| BBIO | Stock | Healthcare | US$ 13.15 B | 2,39% | |
Swedish Orphan Biovitrum AB (publ)
|
SOBI | Stock | Healthcare | US$ 148.88 B | 2,38% |
| RPRX | Stock | Healthcare | US$ 33.03 B | 2,37% | |
| ARGX | Stock | Healthcare | US$ 57.16 B | 2,36% | |
|
Innocare Pharma Ltd
|
9969 | Stock | Healthcare | US$ 24.09 B | 2,35% |
|
Chugai Pharmaceutical Co. Ltd.
|
4519 | - | Healthcare | - | 2,32% |
| TVTX | Stock | Healthcare | US$ 5.37 B | 2,32% | |
|
Arbutus Biopharma Corp
|
TKM | Stock | Other | - | 2,29% |
| BMRN | Stock | Healthcare | US$ 11.07 B | 2,28% | |
| SNDX | Stock | Healthcare | US$ 1.57 B | 2,27% | |
Pharma Mar SAU
|
PHMMF | Stock | Healthcare | US$ 1.64 B | 2,21% |
| ALNY | Stock | Healthcare | US$ 29.40 B | 2,19% | |
Ipsen SA
|
IPN | Stock | Healthcare | US$ 11.51 B | 2,18% |
| MIRM | Stock | Healthcare | US$ 5.38 B | 2,18% | |
| BCRX | Stock | Healthcare | US$ 2.09 B | 2,17% | |
| KMPH | Stock | Healthcare | US$ 200.47 M | 2,13% | |
| SRPT | Stock | Healthcare | US$ 1.85 B | 2,06% | |
| IONS | Stock | Healthcare | US$ 7.24 B | 1,99% | |
Pharming Group NV
|
PHARM | Stock | Healthcare | US$ 685.84 M | 1,67% |
Average Investor10 user rating
4.0
(0 people)
L&G Pharma Breakthrough UCITS ETF (Ireland) is an exchange-traded fund (ETF), with assets under management totaling $20.92 million.
Over the past 12 months, L&G Pharma Breakthrough UCITS ETF recorded a return of 8.11%, with its price trading between $12.67 and $15.95 during the same period.
The ETF is traded under the ticker BIGT.
The current price of BIGT is $14.47. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
BIGT is currently trading at $14.47, with a market capitalization of approximately $20.920.000,00. Over the past year, the ETF has delivered a 8.11% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in BIGT through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol BIGT, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, BIGT has returned -7.04%, and 8.11% over the past year.
If you were to purchase 100 shares of BIGT at the current price of $14.47, your total investment would be $1,447.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
